{"text": ["Glaxo", "(GSK)", "Beats", "on", "Q4", "Earnings,", "to", "Focus", "on", "Oncology", "in", "'19"], "created_at": "2019-02-07 16:19:36"}
{"text": ["Glaxo", "(GSK)", "Beats", "on", "Q4", "Earnings,", "to", "Focus", "on", "Oncology", "in", "'19"], "created_at": "2019-02-07 16:19:36"}
{"text": ["Glaxo", "(GSK)", "Beats", "on", "Q4", "Earnings,", "to", "Focus", "on", "Oncology", "in", "'19"], "created_at": "2019-02-07 14:00:02"}
{"text": ["Novartis", "CEO", "lauds", "Trump", "administration", "plan", "to", "overhaul", "rebates"], "created_at": "2019-02-07 06:44:48"}
{"text": ["Novartis", "CEO", "says", "U.S.", "rebate", "plan", "will", "return", "cash", "to", "patients"], "created_at": "2019-02-07 04:56:48"}
